<!DOCTYPE HTML PUBLIC "sanofi-s8_0603">


<HTML>
<HEAD>
   <TITLE>sanofi-s8_0603 -- Converted by SECPublisher 2.1.1.6, created by BCL Technologies Inc., for SEC Filing</TITLE>
   <META name="HandheldFriendly" content="true">
</HEAD>

<BODY bgcolor="#ffffff">
<div align="right"><FONT size=1 face="serif">Registration No.: 333-</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
</div>
<P align="center">
<B><FONT face="serif">UNITED STATES <br>
</FONT></B><B><FONT face="serif">SECURITIES AND EXCHANGE COMMISSION <br>
Washington, D.C. 20549<br>
</FONT></B><font face="serif">________________</font></P>
<P align="center">
<B><FONT face="serif">Form S-8</FONT></B><B><FONT face="serif"><br>
  </FONT></B><B><FONT face="serif">Registration Statement Under The Securities Act of 1933<br>
________________</FONT></B></P>
<P align="center">
<B><FONT size=5 face="serif">Sanofi-Aventis <br>
</FONT></B><FONT size=2 face="serif">(Exact name of Registrant as Specified in its Charter)</FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
	<TD width=40% nowrap align=center>
<B><FONT size=2 face="serif">Republic of France</FONT></B>&nbsp;
	</TD>
	<TD width=20% nowrap align=left>&nbsp;

	</TD>
	<TD width=40% nowrap align=center>
<B><FONT size=2 face="serif">133529324</FONT></B>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=40% nowrap align=center>
<FONT size=2 face="serif">(State or Other Jurisdiction of</FONT>&nbsp;
	</TD>
	<TD width=20% nowrap align=left>&nbsp;

	</TD>
	<TD width=40% nowrap align=center>
<FONT size=2 face="serif">(I.R.S. Employer</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=40% nowrap align=center>
<FONT size=2 face="serif">Incorporation or Organization)</FONT>&nbsp;
	</TD>
	<TD width=20% nowrap align=left>&nbsp;

	</TD>
	<TD width=40% nowrap align=center>
<FONT size=2 face="serif">Identification No.)</FONT>&nbsp;
	</TD>
</TR>
</TABLE>
<p align="center"> <B><FONT size=2 face="serif">174 avenue de France</FONT></B> <br>
  <B><FONT size=2 face="serif">75013 Paris, France<br>
  </FONT></B><FONT size=2 face="serif"><FONT size=2 face="serif">(Address of Principal Executive<br>
<FONT size=2 face="serif">Offices and Zip Code)</FONT></FONT></FONT></p>
<p align="center"><B><FONT face="serif">Sanofi-Aventis Stock Option Plan 2005</FONT></B><BR>
  <FONT size=2 face="serif">(Full Title of Plan)</FONT><BR>
  <font face="serif">________________</font></p>
<p align="center"> <B><FONT size=2 face="serif">Joseph Haggerty </FONT></B><BR>
  <B><FONT size=2 face="serif">Vice President and General Counsel</FONT></B><FONT size=2 face="serif"> </FONT><BR>
  <B><FONT size=2 face="serif">Aventis Pharmaceuticals </FONT></B><BR>
  <B><FONT size=2 face="serif">300 Somerset Corporate Boulevard</FONT></B><FONT size=2 face="serif"> </FONT><BR>
  <B><FONT size=2 face="serif">Bridgewater, New Jersey 08807 </FONT></B><BR>
  <FONT size=2 face="serif"> (Name and Address of Agent for Service)</FONT><FONT face="serif"> </FONT><BR>
  <B><FONT size=2 face="serif">(908) 243-6000</FONT></B><BR>
  <FONT size=2 face="serif">(Telephone Number, Including Area Code, of Agent for Service)</FONT><BR>
<font face="serif">________________</font></p>
<table width="100%"  border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="33%">&nbsp;</td>
    <td width="20%"> <div align="center"><I><FONT size=2 face="serif">Copies to:</FONT></I> </div></td>
    <td width="33%">&nbsp;</td>
  </tr>
  <tr>
    <td><div align="center"><FONT size=2 face="serif">Jean-Pierre Kerjouan</FONT>&nbsp; </div></td>
    <td width="20%">&nbsp;</td>
    <td><div align="center"><FONT size=2 face="serif">Arthur Kohn, Esq.</FONT>&nbsp; </div></td>
  </tr>
  <tr>
    <td> <div align="center"><FONT size=2 face="serif">Senior Vice President and Advisor to the President</FONT>&nbsp; </div></td>
    <td width="20%">&nbsp;</td>
    <td><div align="center"><FONT size=2 face="serif">Cleary Gottlieb Steen &amp; Hamilton LLP</FONT>&nbsp; </div></td>
  </tr>
  <tr>
    <td><div align="center"><FONT size=2 face="serif">Sanofi-Aventis</FONT>&nbsp; </div></td>
    <td width="20%">&nbsp;</td>
    <td><div align="center"><FONT size=2 face="serif">One Liberty Plaza</FONT>&nbsp; </div></td>
  </tr>
  <tr>
    <td><div align="center"><FONT size=2 face="serif">174 avenue de France</FONT>&nbsp;</div></td>
    <td width="20%">&nbsp;</td>
    <td><div align="center"><FONT size=2 face="serif">New York, NY 10006</FONT>&nbsp; </div></td>
  </tr>
  <tr>
    <td><div align="center"><FONT size=2 face="serif">75013 Paris, France</FONT>&nbsp; </div></td>
    <td width="20%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
</table>
<br>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
	<TD colspan=5 align=center>
<B><FONT size=2 face="serif">Calculation of Registration Fee</FONT></B>
	</TD>
  </TR>
<TR>
	<TD colspan=5>
<HR noshade size=1>
	</TD>
  </TR>
<TR valign="bottom">
	<TD width=28% nowrap align=left>&nbsp;

	</TD>
	<TD width=18% nowrap align=left>&nbsp;

	</TD>
	<TD width=18% nowrap align=center>
<B><FONT size=1 face="serif">Proposed</FONT></B>&nbsp;
	</TD>
	<TD width=18% nowrap align=left>
 <div align="center"><B><FONT size=1 face="serif">Proposed</FONT></B>&nbsp;
    </div></TD>
	<TD width=18% nowrap align=left>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=28% nowrap align=left>&nbsp;

	</TD>
	<TD width=18% nowrap align=left>&nbsp;

	</TD>
	<TD width=18% nowrap align=center>
<B><FONT size=1 face="serif">Maximum</FONT></B>&nbsp;
	</TD>
	<TD width=18% nowrap align=left>
 <div align="center"><B><FONT size=1 face="serif">Maximum</FONT></B>&nbsp;
    </div></TD>
	<TD width=18% nowrap align=center>
<B><FONT size=1 face="serif">Amount</FONT></B>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=28% nowrap align=left>
 <div align="center"><B><FONT size=1 face="serif">Title of Each Class of</FONT></B>&nbsp;
    </div></TD>
	<TD width=18% nowrap align=right>
      <div align="center"><B><FONT size=1 face="serif">Amount to</FONT></B>&nbsp;
      </div></TD>
	<TD width=18% nowrap align=center>
<B><FONT size=1 face="serif">Offering</FONT></B>&nbsp;
	</TD>
	<TD width=18% nowrap align=left>
 <div align="center"><B><FONT size=1 face="serif">Aggregate</FONT></B>&nbsp;
    </div></TD>
	<TD width=18% nowrap align=center>
<B><FONT size=1 face="serif">of</FONT></B>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=28% nowrap align=left>
 <div align="center"><B><FONT size=1 face="serif">Securities to Be</FONT></B>&nbsp;
    </div></TD>
	<TD width=18% nowrap align=right>
      <div align="center"><B><FONT size=1 face="serif">be</FONT></B>&nbsp;
      </div></TD>
	<TD width=18% nowrap align=center>
<B><FONT size=1 face="serif">Price</FONT></B>&nbsp;
	</TD>
	<TD width=18% nowrap align=left>
 <div align="center"><B><FONT size=1 face="serif">Offering</FONT></B>&nbsp;
    </div></TD>
	<TD width=18% nowrap align=center>
<B><FONT size=1 face="serif">Registration</FONT></B>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=28% nowrap align=left>
 <div align="center"><B><FONT size=1 face="serif">Registered</FONT></B>&nbsp;
    </div></TD>
	<TD width=18% nowrap align=right>
      <div align="center"><B><FONT size=1 face="serif">Registered (1)</FONT></B>&nbsp;
      </div></TD>
	<TD width=18% nowrap align=center>
<B><FONT size=1 face="serif">Per Share (2)</FONT></B>&nbsp;
	</TD>
	<TD width=18% nowrap align=left>
 <div align="center"><B><FONT size=1 face="serif">Price(3)</FONT></B>&nbsp;
    </div></TD>
	<TD width=18% nowrap align=center>
<B><FONT size=1 face="serif">Fee (4)</FONT></B>&nbsp;
	</TD>
</TR>
<TR>
	<TD width="28%">
<HR noshade size=1>
	</TD>
	<TD width="18%">
<HR align="center" size=1 noshade>
	</TD>
	<TD width="18%">
<HR noshade size=1>
	</TD>
	<TD width="18%">
<HR noshade size=1>
	</TD>
	<TD width="18%">
<HR noshade size=1>
	</TD>
</TR>
<TR valign="bottom">
	<TD width=28% nowrap align=center>
<FONT size=1 face="serif">Sanofi-Aventis Ordinary Shares, nominal value &euro;2</FONT>&nbsp;
	</TD>
	<TD width=18% nowrap align=right>
      <div align="center"><FONT size=1 face="serif">4,600,000</FONT>&nbsp;
      </div></TD>
	<TD width=18% nowrap align=center>
<FONT size=1 face="serif">$86.32</FONT>&nbsp;
	</TD>
	<TD width=18% nowrap align=center>
<FONT size=1 face="serif">$397,109,296.80</FONT>&nbsp;
	</TD>
	<TD width=18% nowrap align=center>
<FONT size=1 face="serif">$46,739.76</FONT>&nbsp;
	</TD>
</TR>
<TR>
	<TD width="28%">
      <HR noshade size=1>
	</TD>
	<TD width="18%">
<HR noshade size=1>
	</TD>
	<TD width="18%">
<HR noshade size=1>
	</TD>
	<TD width="18%">
<HR noshade size=1>
	</TD>
	<TD width="18%">
<HR noshade size=1>
	</TD>
</TR>
</TABLE>
<br>
________________________
<BR>
<TABLE border=0 cellspacing=0 cellpadding=0>
<TR>
	<TD width="26" valign=top nowrap>
<FONT size=1 face="serif">(1)</FONT></TD>
	<TD width="948">
<FONT size=1 face="serif">Together with an indeterminate number of ordinary shares that may be necessary to adjust the number of shares reserved for issuance pursuant to the Sanofi-Aventis Stock Option Plan 2005 as a result of stock splits, stock
dividends or similar adjustments of the outstanding Ordinary Shares of Sanofi-Aventis (the &#147;Registrant&#148;).</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=1 face="serif">(2)</FONT></TD>
	<TD>
<FONT size=1 face="serif">Calculated solely for the purposes of this offering under Rule 457(h) of the Securities Act of 1933, on the basis of the exercise price of the outstanding options issuable upon exercise pursuant to this plan based upon the
price in euros at which these options can be exercised (&euro;70.38 each) and converted into U.S. dollars on the basis of an exchange rate of 1 euro = $1.2266, which was the Federal Reserve Bank of New York noon buying rate on June 2,
2005.</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=1 face="serif">(3)</FONT></TD>
	<TD>
<FONT size=1 face="serif">Calculated as the product of (x) the number of Sanofi-Aventis ordinary shares to be registered and (y) the exercise price of the related options.</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=1 face="serif">(4)</FONT></TD>
	<TD>
<FONT size=1 face="serif">Calculated as the product of (x) 0.0001177 and (y) the Proposed Maximum Aggregate Offering Price.</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR></TABLE>
<div align="center">
  <p>&nbsp;</p>
</div>
<HR noshade align="center" width="100%" size=2>


<div align="center"><A name="page_3"></A>

  <B><FONT size=2 face="serif">PART I</FONT></B><BR>
</div>
<P align="center">
<B><FONT size=2 face="serif">INFORMATION REQUIRED IN THE PROSPECTUS</FONT></B></P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
  <TR><TD width="6%" valign="top" nowrap>
<B><FONT size=2 face="serif">Item 1.</FONT></B><BR>
</TD>
    <TD width="94%" nowrap> <B><FONT size=2 face="serif">Plan Information</FONT></B></TD>
  </TR>
  <TR>
    <TD nowrap>&nbsp;</TD>
    <TD nowrap>&nbsp;</TD>
  </TR>
  <TR>
    <TD nowrap>&nbsp;</TD>
    <TD nowrap> <FONT size=2 face="serif"> Omitted pursuant to the instructions and provisions of Form S-8. </FONT></TD>
  </TR>
  <TR>
    <TD nowrap>&nbsp;</TD>
    <TD nowrap>&nbsp;</TD>
  </TR>
  <TR>
    <TD nowrap> <B><FONT size=2 face="serif">Item 2. </FONT></B></TD>
    <TD nowrap><B><FONT size=2 face="serif">Registrant Information and Employee Plan Annual Information</FONT></B><FONT size=2 face="serif">&nbsp; </FONT></TD>
  </TR>
  <TR>
    <TD nowrap>&nbsp;</TD>
    <TD nowrap>&nbsp;</TD>
  </TR>
  <TR>
    <TD nowrap>&nbsp;</TD>
    <TD nowrap> <FONT size=2 face="serif"> Omitted pursuant to the instructions and provisions of Form S-8. </FONT></TD>
  </TR>
  <TR>
    <TD nowrap>&nbsp;</TD>
    <TD nowrap>&nbsp;</TD>
  </TR>
  <TR>
    <TD nowrap>&nbsp;</TD>
    <TD nowrap>&nbsp;</TD>
  </TR>
  <TR>
    <TD colspan="2" nowrap><div align="center"><B><FONT size=2 face="serif">PART II <br>
    </FONT></B><B><FONT size=2 face="serif">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</FONT></B></div></TD>
  </TR>
  <TR>
    <TD colspan="2" nowrap>&nbsp;</TD>
  </TR>
  <TR>
    <TD nowrap> <B><FONT size=2 face="serif">Item 3. </FONT></B><BR></TD>
    <TD nowrap><B><FONT size=2 face="serif">Incorporation of Documents by Reference</FONT></B></TD>
  </TR>
</TABLE>
<P align="left"><FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Registration Statement on Form S-8 hereby incorporates by reference the contents of the following reports of the Registrant filed with, or furnished to, the Securities and Exchange Commission (the &#147;Commission&#148;) pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act"): </FONT></P>
<P>
<FONT size=2 face="serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Annual Report on Form 20-F of the Registrant for the year ended December 31, 2004 (the &#147;Form 20-F&#148;) (Commission file No. 001-31368); </FONT></P>
<P>
<FONT size=2 face="serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Reports on Form 6-K furnished by the Registrant to the Commission pursuant to Section 13(a) or 15(d) of the Exchange Act on the following dates: January 6, 2005; January 18, 2005; January 20, 2005; January 26,
2005; February 24, 2005; March 1, 2005; March 3, 2005; March 14, 2005; March 23, 2005; March 31, 2005; April 4, 2005; April 8, 2005; April 21, 2005; May 10, 2005; May 13, 2005; May 17, 2005; May 18, 2005; and June 1, 2005; </FONT></P>
<P>
<FONT size=2 face="serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The description of the Registrant&#146;s ordinary shares, nominal value &euro;2 per share, set forth under the captions &#147;A. Share Capital&#148; and &#147;B. Memorandum and Articles of Association&#148; in Item 10
of the Registrant&#146;s Registration Statement on Form 20-F (Commission file No. 001-31368), filed with the Commission on April 11, 2005 and the updated descriptions of the Registrant&#146;s American depositary shares contained in the
Post-Effective Amendment No. 3 to the Registration Statement on Form F-4 (Registration No. 333-112314) (the &#147;Form F-4&#148;) filed by the Registrant with the Commission on November 9, 2004, under the caption &#147;Description of Sanofi-Aventis
American Depositary Shares&#148;, including any amendment or report filed for the purpose of updating such description; and</FONT></P>
<P>
<FONT size=2 face="serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) All documents filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act prior to the filing of a post-effective amendment indicating that all securities offered
have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such document incorporated by reference.
Statements contained in the foregoing documents incorporated by reference shall be deemed to be modified or superseded hereby to the extent that statements contained in the Prospectus, or in any subsequently filed documents that are amendments
hereto or that are incorporated herein by reference, shall modify or replace such statements. </FONT></P>
<P> <B><FONT size=2 face="serif">Item 4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Description of Securities</FONT></B></P>
<P>  <FONT size=2 face="serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information required by Item 4 is not applicable to this Registration Statement because the class of securities to be offered is registered under Section 12 of the Exchange Act. </FONT></P>
<P> <B><FONT size=2 face="serif">Item 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interests of named Experts and Counsel</FONT></B></P>
<P>&nbsp;<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information required by Item 5 is not applicable to this Registration Statement.</FONT></P>
<P>&nbsp;</P>
<HR noshade align="center" width="100%" size=2>


<p><A name="page_4"></A>
</p>
<p> <B><FONT size=2 face="serif">Item 6. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indemnification of Directors and Officers</FONT></B><br>
  <BR>
  <FONT size=2 face="serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The French Commercial Code prohibits provisions of </FONT><I><FONT size=2 face="serif">statuts </FONT></I><FONT size=2 face="serif">that limit the liability of directors. However, if a director is sued by a third party and
ultimately prevails in the litigation on all counts, but is nevertheless required to bear attorneys&#146; fees and costs, the company may reimburse those fees and costs pursuant to an indemnification arrangement with the director.</FONT></p>
<P>
<FONT size=2 face="serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under French law a company may purchase directors and officers&#146; insurance for all or part of the members of its management. A French corporation is responsible to third parties for the consequences of the decisions of
its board of directors. However, if those decisions qualify as mismanagement, the relevant member of the board of directors may have to fully or partly indemnify the company. Sanofi-Aventis has purchased insurance for all of its
directors.</FONT></P>
<P> <B><FONT size=2 face="serif">Item 7. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exemption from Registration Claimed</FONT></B><br>
  <BR>
  <FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information required by Item 7 is not applicable to this Registration Statement.</FONT></P>
<P> <B><FONT size=2 face="serif">Item 8.</FONT></B>&nbsp;&nbsp;&nbsp;&nbsp; <B><FONT size=2 face="serif">Exhibits</FONT></B></P>
<TABLE border=0 cellspacing=0 cellpadding=0>
<TR>
	<TD width="70" valign=top nowrap>
<FONT size=2 face="serif">4.1</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD width="904">
<FONT size=2 face="serif">Bylaws (</FONT><I><FONT size=2 face="serif">statuts</FONT></I><FONT size=2 face="serif">) of Sanofi-Aventis (incorporated herein by reference to Exhibit 1.1 of the Annual Report on Form 20-F of the Registrant for the year
ended December 31, 2004 (the &#147;Form 20-F&#148;) (Commission file No. 001-31368) as filed by the Registrant with the Commission on April 11, 2005)</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">4.2</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Deposit Agreement (including the form of depositary receipt) between the Registrant and The Bank of New York, as depositary (incorporated herein by reference to Exhibit A to the Registration Statement on Form F-6
(Registration No. 333-116262) relating to American Depositary Shares, filed with the Commission on June 8, 2004)</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">4.3</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Resolution Number 14 of the General Meeting of the Shareholders of sanofi-aventis held on May 31, 2005 (English translation)</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">4.4</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Rules and Regulations of Sanofi-Aventis Stock Option Plan 2005</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">5</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Opinion of Patricia Kodyra regarding the validity of the Registrant&#146;s ordinary shares being registered</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">23.1</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Consent of PricewaterhouseCoopers Audit</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">23.2</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Consent of Ernst &amp; Young Audit</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">23.3</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Consent of Patricia Kodyra (included in Exhibit 5 above)</FONT>	</TD>
</TR>
</TABLE>
<p> <FONT size=2 face="serif">Item 9.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <FONT size=2 face="serif">Undertakings</FONT></p>
<p> <FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned Registrant hereby undertakes:</FONT><BR>
<BR>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT size=2 face="serif"> (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement to include any material information with respect to the plan of distribution not previously
disclosed in the Registration Statement or any material change to such information in the Registration Statement, </FONT></p>
<HR noshade align="center" width="100%" size=2>


<A name="page_5"></A>

<P>
<FONT size=2 face="serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </FONT></P>
<P>
<FONT size=2 face="serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering. </FONT></P>
<P>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif"> The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a)
or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be
the initial </FONT><I><FONT size=2 face="serif">bona fide</FONT></I><FONT size=2 face="serif"> offering thereof. </FONT></P>
<P>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT size=2 face="serif">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers, and controlling persons of the Registrant pursuant to the provisions
described in Item 6 of this Registration Statement, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer, or controlling person of the Registrant in the successful defense of
any action, suit, or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </FONT></P>
<HR noshade align="center" width="100%" size=2>


<p><A name="page_6"></A>
</p>
<p align="center"><B><FONT face="serif">SIGNATURES</FONT></B> </p>

<P>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in Paris, France, on June 3, 2005. </FONT></P>
<TABLE><TR><TD nowrap>&nbsp;</TD>
</TR></TABLE>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=1>
<TR valign="bottom">
  <TD height="46" align=left nowrap>&nbsp;</TD>
  <TD colspan="2" align=left valign="top" nowrap> <FONT size=2 face="serif">SANOFI-AVENTIS</FONT></TD>
  </TR>
<TR valign="bottom">
  <TD width=52% nowrap align=left>&nbsp;</TD>
	<TD width=4% nowrap align=left>
<FONT size=2 face="serif">By:</FONT>&nbsp;
	</TD>
	<TD width=44% nowrap align=left>
 &nbsp;<FONT size=2 face="serif">\s\ Jean-Fran&ccedil;ois Dehecq</FONT>&nbsp;
	</TD>
</TR>
<TR>
  <TD>&nbsp;</TD>
	<TD>&nbsp;
	</TD>
	<TD>
<HR align="left" width="250" size=1 noshade>
	</TD>
</TR>
<TR valign="bottom">
  <TD width=52% nowrap align=left>&nbsp;</TD>
	<TD width=4% nowrap align=left>
<FONT size=2 face="serif">Name:</FONT>&nbsp;
	</TD>
	<TD width=44% nowrap align=left>
<FONT size=2 face="serif">Jean-Fran&ccedil;ois Dehecq</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
  <TD width=52% nowrap align=left>&nbsp;</TD>
	<TD width=4% nowrap align=left>
<FONT size=2 face="serif">Title:</FONT>&nbsp;
	</TD>
	<TD width=44% nowrap align=left>
<FONT size=2 face="serif">Chairman &amp; Chief Executive Officer</FONT>&nbsp;
	</TD>
</TR>
</TABLE>
<BR>
<P>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons in the capacities and on the dates
indicated:</FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD width=32% nowrap align=center><B><FONT size=2 face="serif">Signature</FONT></B></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center>
<B><FONT size=2 face="serif">Title</FONT></B>&nbsp;
	</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center>
<B><FONT size=2 face="serif">Date</FONT></B>&nbsp;
	</TD>
</TR>
<TR>
  <TD><HR noshade size=1></TD>
  <TD>&nbsp;</TD>
  <TD><HR noshade size=1></TD>
  <TD>&nbsp;</TD>
  <TD><HR noshade size=1></TD>
</TR>
<TR>
  <TD width="32%">&nbsp;</TD>
	<TD width="2%">&nbsp;</TD>
	<TD width="32%">&nbsp;
	</TD>
	<TD width="2%">&nbsp;</TD>
	<TD width="32%">&nbsp;
	</TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center> <I><FONT size=2 face="serif">\s\ Jean-Fran&ccedil;ois Dehecq</FONT></I></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% rowspan="3" align=center valign="middle" nowrap>
<FONT size=2 face="serif">Chairman, Chief Executive Officer and</FONT>&nbsp;
<FONT size=2 face="serif"><br>
Director (Principal Executive Officer)</FONT>&nbsp;
	</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=32% align=center nowrap><hr size="1" noshade></TD>
  <TD width=2% align=center nowrap>&nbsp;</TD>
  <TD width=2% align=center nowrap>&nbsp;</TD>
  <TD width=32% align=left nowrap> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp; </div></TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center> <FONT size=2 face="serif">Jean-Fran&ccedil;ois Dehecq </FONT></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=left>

	  <div align="center"></div></TD>
</TR>
<TR valign="bottom">
  <TD width=32% align=center nowrap>&nbsp;</TD>
  <TD width=2% align=center nowrap>&nbsp;</TD>
  <TD width=32% align=center nowrap>&nbsp;</TD>
  <TD width=2% align=center nowrap>&nbsp;</TD>
  <TD width=32% align=center nowrap><div align="center"></div></TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center> <I><FONT size=2 face="serif">\s\ Jean-Claude Leroy</FONT></I></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% rowspan="3" align=center valign="middle" nowrap>
<FONT size=2 face="serif">Senior Vice President and Chief Financial</FONT>&nbsp;
<FONT size=2 face="serif"><br>
Officer (Principal Financial Officer)</FONT>&nbsp;
	</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center><div align="center"></div></TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center><hr size="1" noshade></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=left> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp; </div></TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center> <FONT size=2 face="serif">Jean-Claude Leroy </FONT></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=left>

	  <div align="center"></div></TD>
</TR>
<TR valign="bottom">
  <TD width=32% align=center nowrap>&nbsp;</TD>
  <TD width=2% align=center nowrap>&nbsp;</TD>
  <TD width=32% align=center nowrap>&nbsp;</TD>
  <TD width=2% align=center nowrap>&nbsp;</TD>
  <TD width=32% align=center nowrap><div align="center"></div></TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center> <I><FONT size=2 face="serif">\s\ Jean-Luc Renard</FONT></I></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% rowspan="3" align=center valign="middle" nowrap>
<FONT size=2 face="serif">Vice President Corporate Accounting and Tax</FONT>&nbsp;
<FONT size=2 face="serif"><br>
(Principal Accounting Officer)</FONT>&nbsp;
	</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center><div align="center"></div></TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center><hr size="1" noshade></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=left> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp; </div></TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center> <FONT size=2 face="serif">Jean-Luc Renard </FONT></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
  <TD width=32% align=center nowrap>&nbsp;</TD>
  <TD width=2% align=center nowrap>&nbsp;</TD>
  <TD width=32% align=center nowrap>&nbsp;</TD>
  <TD width=2% align=center nowrap>&nbsp;</TD>
  <TD width=32% align=center nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center> <I><FONT size=2 face="serif">\s\ Ren&eacute; Barbier de la Serre</FONT></I></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% rowspan="3" align=center valign="middle" nowrap>
<FONT size=2 face="serif">Director</FONT>&nbsp;
	</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center><hr size="1" noshade></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center> <FONT size=2 face="serif">June 3, 2005</FONT>&nbsp; </TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center> <FONT size=2 face="serif">Ren&eacute; Barbier de la Serre </FONT></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center> <I><FONT size=2 face="serif">\s\ Jean-Marc Bruel</FONT></I></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% rowspan="3" align=center valign="middle" nowrap>
<FONT size=2 face="serif">Director</FONT>&nbsp;
	</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center><hr size="1" noshade></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center> <FONT size=2 face="serif">June 3, 2005</FONT>&nbsp; </TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center> <FONT size=2 face="serif">Jean-Marc Bruel </FONT></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=32% align=center nowrap> <I><FONT size=2 face="serif">\s\ Robert Castaigne</FONT></I></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD width=32% rowspan="3" align=center valign="middle" nowrap>
<FONT size=2 face="serif">Director</FONT>&nbsp;	</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=center nowrap><hr size="1" noshade></TD>
  <TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
  <TD align=center nowrap> <FONT size=2 face="serif">Robert Castaigne </FONT></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center> <I><FONT size=2 face="serif">\s\ Thierry Desmarest</FONT></I></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD width=32% rowspan="3" align=center valign="middle" nowrap>
<FONT size=2 face="serif">Director</FONT>&nbsp;	</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center><hr size="1" noshade></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center> <FONT size=2 face="serif">Thierry Desmarest </FONT></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center> <I><FONT size=2 face="serif">\s\ J&uuml;rgen Dormann</FONT></I></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD width=32% rowspan="3" align=center valign="middle" nowrap>
<FONT size=2 face="serif">Director</FONT>&nbsp;	</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center><hr size="1" noshade></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center> <FONT size=2 face="serif">J&uuml;rgen Dormann </FONT></TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
  <TD nowrap align=center>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center><hr size="1" noshade></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">Director</FONT>&nbsp;
	</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center>&nbsp;
</TD>
</TR>
<TR valign="bottom">
  <TD width=32% nowrap align=center> <FONT size=2 face="serif">Lord Douro</FONT><BR></TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=center>&nbsp;</TD>
	<TD width=2% nowrap align=center>&nbsp;</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
</TR>
</TABLE>
<p>&nbsp;</p>
<HR noshade align="center" width="100%" size=2>


<p><A name="page_7"></A>
</p>
<p>&nbsp; </p>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<B><FONT size=2 face="serif">Signature</FONT></B>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>
<B><FONT size=2 face="serif">Title</FONT></B>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>
<B><FONT size=2 face="serif">Date</FONT></B>&nbsp;
	</TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%">
<HR noshade size=1>	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<I><FONT size=2 face="serif">\s\ Jean-Ren&eacute; Fourtou</FONT></I>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>&nbsp;</TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%"><div align="center"><FONT size=2 face="serif">Director</FONT>
    </div></TD>
	<TD width="2%">
	</TD>
	<TD width="32%"> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;	  </div></TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">Jean-Ren&eacute; Fourtou</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>

	  <div align="center"></div></TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center><div align="center"></div></TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%"><div align="center"><FONT size=2 face="serif">Director</FONT>
    </div></TD>
	<TD width="2%">
	</TD>
	<TD width="32%"> <div align="center"></div></TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">Serge Kampf</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>

	  <div align="center"></div></TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<I><FONT size=2 face="serif">\s\ Igor Landau</FONT></I>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center><div align="center"></div></TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%"><div align="center"><FONT size=2 face="serif">Director</FONT>
    </div></TD>
	<TD width="2%">
	</TD>
	<TD width="32%"> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;	  </div></TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">Igor Landau</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>

	  <div align="center"></div></TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<I><FONT size=2 face="serif">\s\ Hubert Markl</FONT></I>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center><div align="center"></div></TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%"><div align="center"><FONT size=2 face="serif">Director</FONT>
    </div></TD>
	<TD width="2%">
	</TD>
	<TD width="32%"> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;	  </div></TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">Hubert Markl</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<I><FONT size=2 face="serif">\s\ Christian Mulliez</FONT></I>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>&nbsp;</TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%"><div align="center"><FONT size=2 face="serif">Director</FONT>
    </div></TD>
	<TD width="2%">
	</TD>
	<TD width="32%"> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;	  </div></TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">Christian Mulliez</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>

	  <div align="center"></div></TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center><div align="center"></div></TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%"><div align="center"><FONT size=2 face="serif">Director</FONT>
    </div></TD>
	<TD width="2%">
	</TD>
	<TD width="32%"> <div align="center"></div></TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">Lindsay Owen-Jones</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>

	  <div align="center"></div></TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<I><FONT size=2 face="serif">\s\ Klaus Pohle</FONT></I>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center><div align="center"></div></TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%"><div align="center"><FONT size=2 face="serif">Director</FONT>
    </div></TD>
	<TD width="2%">
	</TD>
	<TD width="32%"> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;	  </div></TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">Klaus Pohle</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>

	  <div align="center"></div></TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<I><FONT size=2 face="serif">\s\ Hermann Scholl</FONT></I>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center><div align="center"></div></TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%"><div align="center"><FONT size=2 face="serif">Director</FONT>
    </div></TD>
	<TD width="2%">
	</TD>
	<TD width="32%"> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;	  </div></TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">Hermann Scholl</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>

	  <div align="center"></div></TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<I><FONT size=2 face="serif">\s\ G&eacute;rard Van Kemmel</FONT></I>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center><div align="center"></div></TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%"><div align="center"><FONT size=2 face="serif">Director</FONT>
    </div></TD>
	<TD width="2%">
	</TD>
	<TD width="32%"> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;	  </div></TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">G&eacute;rard Van Kemmel</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>

	  <div align="center"></div></TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<I><FONT size=2 face="serif">\s\ Bruno Weymuller</FONT></I>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center><div align="center"></div></TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%"><div align="center"><FONT size=2 face="serif">Director</FONT>
    </div></TD>
	<TD width="2%">
	</TD>
	<TD width="32%"> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;	  </div></TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">Bruno Weymuller</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>

	  <div align="center"></div></TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR>
	<TD colspan=5>&nbsp;

	</TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<I><FONT size=2 face="serif">\s\ Joseph Haggerty</FONT></I>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% rowspan="3" align=center valign="middle" nowrap>
<FONT size=2 face="serif">Authorized Representative in the United</FONT>&nbsp;
<FONT size=2 face="serif"><br>
States of America</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=center><div align="center"></div></TD>
</TR>
<TR>
	<TD width="32%">
<HR noshade size=1>	</TD>
	<TD width="2%">
	</TD>
	<TD width="2%">
	</TD>
	<TD width="32%"> <div align="center"><FONT size=2 face="serif">June 3, 2005</FONT>&nbsp;	  </div></TD>
</TR>
<TR valign="bottom">
	<TD width=32% nowrap align=center>
<FONT size=2 face="serif">Joseph Haggerty</FONT>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=2%>&nbsp;
	</TD>
	<TD width=32% nowrap align=left>&nbsp;

	</TD>
</TR>
</TABLE>
<BR>
<HR noshade align="center" width="100%" size=2>


<p><A name="page_8"></A>
</p>
<p align="center"> <B><FONT size=2 face="serif">EXHIBIT INDEX</FONT></B><BR>
</p>
<TABLE border=0 cellspacing=0 cellpadding=0>
<TR>
	<TD width="61" valign=top nowrap>
<FONT size=2 face="serif">4.1</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD width="913">
<FONT size=2 face="serif">Bylaws (</FONT><I><FONT size=2 face="serif">statuts</FONT></I><FONT size=2 face="serif">) of Sanofi-Aventis (incorporated herein by reference to Exhibit 1.1 of the Annual Report on Form 20-F of the Registrant for the year
ended December 31, 2004 (the &#147;Form 20-F&#148;) (Commission file No. 001-31368) as filed by the Registrant with the Commission on April 11, 2005)</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">4.2</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Deposit Agreement (including the form of depositary receipt) between the Registrant and The Bank of New York, as depositary (incorporated herein by reference to Exhibit A to the Registration Statement on Form F-6
(Registration No. 333-116262) relating to American Depositary Shares, filed with the Commission on June 8, 2004)</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">4.3</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Resolution Number 14 of the General Meeting of the Shareholders of sanofi-aventis held on May 31, 2005 (English translation)</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">4.4</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Rules and Regulations of Sanofi-Aventis Stock Option Plan 2005</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">5</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Opinion of Patricia Kodyra regarding the validity of the Registrant&#146;s ordinary shares being registered</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">23.1</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Consent of PricewaterhouseCoopers Audit</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">23.2</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Consent of Ernst &amp; Young Audit</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
	<TD nowrap valign=top>
<FONT size=2 face="serif">23.3</FONT>&nbsp; &nbsp; &nbsp; 	</TD>
	<TD>
<FONT size=2 face="serif">Consent of Patricia Kodyra (included in Exhibit 5 above)</FONT>	</TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR>
<TR><TD colspan=2>&nbsp;</TD></TR></TABLE>
<HR noshade align="center" width="100%" size=2>


<A name="page_9"></A>

</BODY>

</HTML>
[{"type": "S-8", "sequence": "1", "filename": "sanofi-s8_0603.htm", "secsgml_size_bytes": 52269}]
{"company-data": {"conformed-name": "SANOFI-AVENTIS", "cik": "0001121404", "assigned-sic": "2834", "irs-number": "133529324", "state-of-incorporation": "I0", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-125490", "film-number": "05877592"}, "business-address": {"street1": "174 AVENUE DE FRANCE", "city": "PARIS", "state": "I0", "zip": "75013", "phone": "33153774400"}, "mail-address": {"street1": "174 AVENUE DE FRANCE", "city": "PARIS", "state": "I0", "zip": "75013"}, "former-company": {"former-conformed-name": "SANOFI SYNTHELABO SA", "date-changed": "20010104"}}
sanofi-s8_0603 -- Converted by SECPublisher 2.1.1.6, created by BCL Technologies Inc., for SEC Filing
Registration No.: 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
Form S-8
Registration Statement Under The Securities Act of 1933
________________
Sanofi-Aventis
(Exact name of Registrant as Specified in its Charter)
Republic of France
133529324
(State or Other Jurisdiction of
(I.R.S. Employer
Incorporation or Organization)
Identification No.)
174 avenue de France
75013 Paris, France
(Address of Principal Executive
Offices and Zip Code)
Sanofi-Aventis Stock Option Plan 2005
(Full Title of Plan)
________________
Joseph Haggerty
Vice President and General Counsel
Aventis Pharmaceuticals
300 Somerset Corporate Boulevard
Bridgewater, New Jersey 08807
(Name and Address of Agent for Service)
(908) 243-6000
(Telephone Number, Including Area Code, of Agent for Service)
________________
Copies to:
Jean-Pierre Kerjouan
Arthur Kohn, Esq.
Senior Vice President and Advisor to the President
Cleary Gottlieb Steen & Hamilton LLP
Sanofi-Aventis
One Liberty Plaza
174 avenue de France
New York, NY 10006
75013 Paris, France
Calculation of Registration Fee
Proposed
Proposed
Maximum
Maximum
Amount
Title of Each Class of
Amount to
Offering
Aggregate
of
Securities to Be
be
Price
Offering
Registration
Registered
Registered (1)
Per Share (2)
Price(3)
Fee (4)
Sanofi-Aventis Ordinary Shares, nominal value €2
4,600,000
$86.32
$397,109,296.80
$46,739.76
________________________
(1)
Together with an indeterminate number of ordinary shares that may be necessary to adjust the number of shares reserved for issuance pursuant to the Sanofi-Aventis Stock Option Plan 2005 as a result of stock splits, stock
dividends or similar adjustments of the outstanding Ordinary Shares of Sanofi-Aventis (the "Registrant").
(2)
Calculated solely for the purposes of this offering under Rule 457(h) of the Securities Act of 1933, on the basis of the exercise price of the outstanding options issuable upon exercise pursuant to this plan based upon the
price in euros at which these options can be exercised (€70.38 each) and converted into U.S. dollars on the basis of an exchange rate of 1 euro = $1.2266, which was the Federal Reserve Bank of New York noon buying rate on June 2,
2005.
(3)
Calculated as the product of (x) the number of Sanofi-Aventis ordinary shares to be registered and (y) the exercise price of the related options.
(4)
Calculated as the product of (x) 0.0001177 and (y) the Proposed Maximum Aggregate Offering Price.
PART I
INFORMATION REQUIRED IN THE PROSPECTUS
Item 1.
Plan Information
Omitted pursuant to the instructions and provisions of Form S-8.
Item 2.
Registrant Information and Employee Plan Annual Information
Omitted pursuant to the instructions and provisions of Form S-8.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Incorporation of Documents by Reference
This Registration Statement on Form S-8 hereby incorporates by reference the contents of the following reports of the Registrant filed with, or furnished to, the Securities and Exchange Commission (the "Commission") pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act"):
(a) The Annual Report on Form 20-F of the Registrant for the year ended December 31, 2004 (the "Form 20-F") (Commission file No. 001-31368);
(b) The Reports on Form 6-K furnished by the Registrant to the Commission pursuant to Section 13(a) or 15(d) of the Exchange Act on the following dates: January 6, 2005; January 18, 2005; January 20, 2005; January 26,
2005; February 24, 2005; March 1, 2005; March 3, 2005; March 14, 2005; March 23, 2005; March 31, 2005; April 4, 2005; April 8, 2005; April 21, 2005; May 10, 2005; May 13, 2005; May 17, 2005; May 18, 2005; and June 1, 2005;
(c) The description of the Registrant's ordinary shares, nominal value €2 per share, set forth under the captions "A. Share Capital" and "B. Memorandum and Articles of Association" in Item 10
of the Registrant's Registration Statement on Form 20-F (Commission file No. 001-31368), filed with the Commission on April 11, 2005 and the updated descriptions of the Registrant's American depositary shares contained in the
Post-Effective Amendment No. 3 to the Registration Statement on Form F-4 (Registration No. 333-112314) (the "Form F-4") filed by the Registrant with the Commission on November 9, 2004, under the caption "Description of Sanofi-Aventis
American Depositary Shares", including any amendment or report filed for the purpose of updating such description; and
(d) All documents filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act prior to the filing of a post-effective amendment indicating that all securities offered
have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such document incorporated by reference.
Statements contained in the foregoing documents incorporated by reference shall be deemed to be modified or superseded hereby to the extent that statements contained in the Prospectus, or in any subsequently filed documents that are amendments
hereto or that are incorporated herein by reference, shall modify or replace such statements.
Item 4.       Description of Securities
The information required by Item 4 is not applicable to this Registration Statement because the class of securities to be offered is registered under Section 12 of the Exchange Act.
Item 5.       Interests of named Experts and Counsel
The information required by Item 5 is not applicable to this Registration Statement.
Item 6.       Indemnification of Directors and Officers
The French Commercial Code prohibits provisions of
statuts
that limit the liability of directors. However, if a director is sued by a third party and
ultimately prevails in the litigation on all counts, but is nevertheless required to bear attorneys' fees and costs, the company may reimburse those fees and costs pursuant to an indemnification arrangement with the director.
Under French law a company may purchase directors and officers' insurance for all or part of the members of its management. A French corporation is responsible to third parties for the consequences of the decisions of
its board of directors. However, if those decisions qualify as mismanagement, the relevant member of the board of directors may have to fully or partly indemnify the company. Sanofi-Aventis has purchased insurance for all of its
directors.
Item 7.       Exemption from Registration Claimed
The information required by Item 7 is not applicable to this Registration Statement.
Item 8.
Exhibits
4.1
Bylaws (
statuts
) of Sanofi-Aventis (incorporated herein by reference to Exhibit 1.1 of the Annual Report on Form 20-F of the Registrant for the year
ended December 31, 2004 (the "Form 20-F") (Commission file No. 001-31368) as filed by the Registrant with the Commission on April 11, 2005)
4.2
Deposit Agreement (including the form of depositary receipt) between the Registrant and The Bank of New York, as depositary (incorporated herein by reference to Exhibit A to the Registration Statement on Form F-6
(Registration No. 333-116262) relating to American Depositary Shares, filed with the Commission on June 8, 2004)
4.3
Resolution Number 14 of the General Meeting of the Shareholders of sanofi-aventis held on May 31, 2005 (English translation)
4.4
Rules and Regulations of Sanofi-Aventis Stock Option Plan 2005
5
Opinion of Patricia Kodyra regarding the validity of the Registrant's ordinary shares being registered
23.1
Consent of PricewaterhouseCoopers Audit
23.2
Consent of Ernst & Young Audit
23.3
Consent of Patricia Kodyra (included in Exhibit 5 above)
Item 9.
Undertakings
The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement to include any material information with respect to the plan of distribution not previously
disclosed in the Registration Statement or any material change to such information in the Registration Statement,
(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering.
The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a)
or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be
the initial
bona fide
offering thereof.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers, and controlling persons of the Registrant pursuant to the provisions
described in Item 6 of this Registration Statement, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer, or controlling person of the Registrant in the successful defense of
any action, suit, or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in Paris, France, on June 3, 2005.
SANOFI-AVENTIS
By:
\s\ Jean-François Dehecq
Name:
Jean-François Dehecq
Title:
Chairman & Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons in the capacities and on the dates
indicated:
Signature
Title
Date
\s\ Jean-François Dehecq
Chairman, Chief Executive Officer and
Director (Principal Executive Officer)
June 3, 2005
Jean-François Dehecq
\s\ Jean-Claude Leroy
Senior Vice President and Chief Financial
Officer (Principal Financial Officer)
June 3, 2005
Jean-Claude Leroy
\s\ Jean-Luc Renard
Vice President Corporate Accounting and Tax
(Principal Accounting Officer)
June 3, 2005
Jean-Luc Renard
\s\ René Barbier de la Serre
Director
June 3, 2005
René Barbier de la Serre
\s\ Jean-Marc Bruel
Director
June 3, 2005
Jean-Marc Bruel
\s\ Robert Castaigne
Director
June 3, 2005
Robert Castaigne
\s\ Thierry Desmarest
Director
June 3, 2005
Thierry Desmarest
\s\ Jürgen Dormann
Director
June 3, 2005
Jürgen Dormann
Director
Lord Douro
Signature
Title
Date
\s\ Jean-René Fourtou
Director
June 3, 2005
Jean-René Fourtou
Director
Serge Kampf
\s\ Igor Landau
Director
June 3, 2005
Igor Landau
\s\ Hubert Markl
Director
June 3, 2005
Hubert Markl
\s\ Christian Mulliez
Director
June 3, 2005
Christian Mulliez
Director
Lindsay Owen-Jones
\s\ Klaus Pohle
Director
June 3, 2005
Klaus Pohle
\s\ Hermann Scholl
Director
June 3, 2005
Hermann Scholl
\s\ Gérard Van Kemmel
Director
June 3, 2005
Gérard Van Kemmel
\s\ Bruno Weymuller
Director
June 3, 2005
Bruno Weymuller
\s\ Joseph Haggerty
Authorized Representative in the United
States of America
June 3, 2005
Joseph Haggerty
EXHIBIT INDEX
4.1
Bylaws (
statuts
) of Sanofi-Aventis (incorporated herein by reference to Exhibit 1.1 of the Annual Report on Form 20-F of the Registrant for the year
ended December 31, 2004 (the "Form 20-F") (Commission file No. 001-31368) as filed by the Registrant with the Commission on April 11, 2005)
4.2
Deposit Agreement (including the form of depositary receipt) between the Registrant and The Bank of New York, as depositary (incorporated herein by reference to Exhibit A to the Registration Statement on Form F-6
(Registration No. 333-116262) relating to American Depositary Shares, filed with the Commission on June 8, 2004)
4.3
Resolution Number 14 of the General Meeting of the Shareholders of sanofi-aventis held on May 31, 2005 (English translation)
4.4
Rules and Regulations of Sanofi-Aventis Stock Option Plan 2005
5
Opinion of Patricia Kodyra regarding the validity of the Registrant's ordinary shares being registered
23.1
Consent of PricewaterhouseCoopers Audit
23.2
Consent of Ernst & Young Audit
23.3
Consent of Patricia Kodyra (included in Exhibit 5 above)